Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 351: 1% w/v of methylene blue is injected intravenously to reverse the toxic effects of which condition?

A. Methaemoglobinemia (Correct Answer)
B. Oxygen toxicity
C. Crohn's disease
D. Lidocaine toxicity

Explanation: **Explanation:** **1. Mechanism of Action (Why A is correct):** Methylene blue is the treatment of choice for **acquired methaemoglobinemia**. In this condition, the ferrous iron ($Fe^{2+}$) in hemoglobin is oxidized to the ferric state ($Fe^{3+}$), which cannot bind oxygen. Methylene blue acts as an exogenous electron carrier. Once injected, it is converted by the enzyme **NADPH-methaemoglobin reductase** into **leukomethylene blue**. Leukomethylene blue then reduces the ferric iron ($Fe^{3+}$) back to the functional ferrous state ($Fe^{2+}$), restoring the oxygen-carrying capacity of the blood. **2. Analysis of Incorrect Options:** * **B. Oxygen toxicity:** Managed by reducing the fraction of inspired oxygen ($FiO_2$) and supportive care; methylene blue has no role here. * **C. Crohn’s disease:** This is an inflammatory bowel disease treated with aminosalicylates, corticosteroids, or biologics (e.g., Infliximab). * **D. Lidocaine toxicity:** Severe systemic toxicity (LAST) is treated with **Intravenous Lipid Emulsion (ILE) 20%**. While lidocaine can *cause* methaemoglobinemia as a side effect, methylene blue treats the resulting condition, not the lidocaine toxicity itself. **3. NEET-PG High-Yield Pearls:** * **Dosage:** 1–2 mg/kg (1% solution) IV over 5 minutes. * **Contraindication:** Methylene blue is contraindicated in patients with **G6PD deficiency**, as it can precipitate severe hemolysis (due to insufficient NADPH to reduce the drug). * **Clinical Sign:** Methaemoglobinemia presents with "chocolate-colored blood" and central cyanosis that does not improve with supplemental oxygen. * **Paradoxical effect:** At very high doses, methylene blue can itself induce methaemoglobinemia.

Question 352: Drugs can cause all of the following pulmonary manifestations except?

A. Atelectasis (Correct Answer)
B. Pulmonary eosinophilia
C. Asthma
D. ARDS

Explanation: **Explanation:** Drug-induced pulmonary disease is a high-yield topic in NEET-PG, as many systemic medications have specific respiratory toxicities. **1. Why Atelectasis is the correct answer:** Atelectasis refers to the collapse of lung tissue (alveoli). It is primarily a **mechanical or obstructive process** (e.g., mucus plugging, tumors, or post-surgical shallow breathing) rather than a direct toxicological effect of drugs on the lung parenchyma. While drugs like opioids can cause hypoventilation which *leads* to atelectasis, it is not considered a direct "drug-induced pulmonary manifestation" in clinical pharmacology. **2. Why the other options are incorrect (Drug-induced causes):** * **Pulmonary Eosinophilia (Löffler’s Syndrome):** Classically caused by **Nitrofurantoin**, Sulfonamides, and NSAIDs. It presents with peripheral eosinophilia and fleeting pulmonary infiltrates. * **Asthma (Bronchospasm):** Frequently triggered by **NSAIDs** (via leukotriene shift), **Beta-blockers** (due to B2 blockade), and Cholinergic drugs. * **ARDS (Non-cardiogenic Pulmonary Edema):** Can be caused by an overdose of **Salicylates (Aspirin)**, Opioids, or certain chemotherapeutic agents like Cytarabine and Gemcitabine. **High-Yield Clinical Pearls for NEET-PG:** * **Pulmonary Fibrosis:** The most common drug-induced interstitial lung disease. Key culprits: **Amiodarone**, **Bleomycin**, **Busulfan**, and Methotrexate. * **Systemic Lupus Erythematosus (SLE) with Pleuritis:** Caused by **Hydralazine, Procainamide, and Isoniazid** (HIP). * **Amiodarone:** Unique because it causes "foamy macrophages" in the alveoli due to phospholipidosis. * **Bleomycin:** Toxicity is dose-dependent and exacerbated by high concentrations of inspired oxygen ($FiO_2$).

Question 353: In which of the following conditions is intravenous immunoglobulin therapy indicated?

A. Myasthenia gravis
B. Idiopathic thrombocytopenic purpura (Correct Answer)
C. Hemolytic-uremic syndrome
D. Multiple myeloma

Explanation: **Explanation:** Intravenous Immunoglobulin (IVIg) is a blood product containing pooled IgG antibodies from thousands of donors. It acts via several mechanisms, including the blockade of Fc receptors on macrophages, neutralization of autoantibodies, and modulation of complement activation. **Why Option B is Correct:** In **Idiopathic Thrombocytopenic Purpura (ITP)**, IVIg is a first-line treatment, especially in acute cases or prior to surgery. The exogenous IgG molecules saturate the Fc receptors on splenic macrophages. This prevents the macrophages from recognizing and destroying antibody-coated platelets, leading to a rapid (though often temporary) rise in platelet count. **Analysis of Incorrect Options:** * **A. Myasthenia Gravis:** While IVIg is used in Myasthenia Gravis, it is typically reserved for **Myasthenic Crisis** or as a pre-operative measure before thymectomy, rather than being the standard maintenance therapy. In the context of this specific question, ITP is the more classic, FDA-approved indication frequently tested in exams. * **C. Hemolytic-uremic Syndrome (HUS):** The mainstay of treatment for HUS is supportive care (fluid management, dialysis). IVIg has no proven role in the management of typical HUS. * **D. Multiple Myeloma:** This is a plasma cell dyscrasia. While IVIg may be used to treat secondary infections due to hypogammaglobulinemia in these patients, it is not a primary treatment for the disease itself. **High-Yield Clinical Pearls for NEET-PG:** * **Common Indications for IVIg:** Kawasaki disease (to prevent coronary artery aneurysms), Guillain-Barré Syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and Common Variable Immunodeficiency (CVID). * **Adverse Effects:** The most common side effect is a flu-like syndrome (fever, chills). A rare but serious complication is **Aseptic Meningitis**. * **Contraindication:** IVIg is contraindicated in patients with **Selective IgA deficiency**, as they may develop life-threatening anaphylaxis due to anti-IgA antibodies.

Question 354: Which of the following drugs cause methemoglobinemia?

A. Aniline
B. Dapsone
C. Nitrates
D. All of the above (Correct Answer)

Explanation: **Explanation:** **Methemoglobinemia** occurs when the iron in hemoglobin is oxidized from the **ferrous state (Fe²⁺)** to the **ferric state (Fe³⁺)**. Ferric iron cannot bind oxygen, and it also increases the oxygen affinity of the remaining ferrous hemes (shifting the oxygen-dissociation curve to the **left**), leading to tissue hypoxia and characteristic "chocolate-colored blood." **Analysis of Options:** * **Aniline (Option A):** Aniline dyes and industrial chemicals are classic oxidizing agents known to induce methemoglobinemia, often seen in occupational exposures. * **Dapsone (Option B):** This is the most common pharmacological cause. It undergoes hepatic metabolism to form hydroxylamine metabolites, which are potent oxidants. This is a critical side effect to monitor in patients treated for Leprosy or *Pneumocystis jirovecii*. * **Nitrates/Nitrites (Option C):** Nitrates (found in well water or medications like Nitroglycerin and Amyl nitrite) are potent triggers. In infants ("Blue Baby Syndrome"), intestinal bacteria convert nitrates to nitrites, which easily oxidize fetal hemoglobin. Since all three substances are well-documented oxidizing agents that convert Fe²⁺ to Fe³⁺, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Sign:** Central cyanosis that does not improve with supplemental oxygen, with normal $PaO_2$ on ABG but low $SaO_2$ (Oxygen saturation gap). * **Drug of Choice:** **Methylene Blue** (acts as a cofactor for NADPH-methemoglobin reductase to reduce Fe³⁺ back to Fe²⁺). * **Contraindication:** Avoid Methylene Blue in patients with **G6PD deficiency**, as it can precipitate hemolysis; use Vitamin C (Ascorbic acid) instead. * **Other common causes:** Benzocaine (local anesthetic), Primaquine, and Sulfonamides.

Question 355: Overexposure to D-penicillamine results in which of the following?

A. Copper toxicity in the retina
B. Sideroblastic anemia (Correct Answer)
C. Hypercoagulable state
D. Dyslipidemia

Explanation: **Explanation:** **D-penicillamine** is a chelating agent used in the treatment of Wilson’s disease, cystinuria, and rheumatoid arthritis. **Why Sideroblastic Anemia is Correct:** D-penicillamine acts as a **Pyridoxine (Vitamin B6) antagonist**. It reacts with pyridoxal phosphate to form a thiazolidine derivative, rendering the vitamin inactive. Pyridoxine is a crucial cofactor for the enzyme **ALAS (delta-aminolevulinate synthase)**, which is the rate-limiting step in heme synthesis. A deficiency or inhibition of this pathway prevents iron from being incorporated into protoporphyrin, leading to iron accumulation in the mitochondria of developing RBCs, visible as "ringed sideroblasts." Thus, overexposure results in **Sideroblastic Anemia**. **Analysis of Incorrect Options:** * **Option A:** D-penicillamine is the treatment of choice for Wilson’s disease; it **removes** copper from the body. It does not cause copper toxicity. * **Option C:** D-penicillamine can actually cause hematological cytopenias (thrombocytopenia) and nephrotic syndrome, but it is not typically associated with a hypercoagulable state. * **Option D:** There is no established clinical link between D-penicillamine and dyslipidemia. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote:** Sideroblastic anemia caused by D-penicillamine or Isoniazid (INH) can be reversed by administering **Pyridoxine (B6)**. * **Other Side Effects:** D-penicillamine is notorious for causing **autoimmune-like syndromes**, including Drug-induced Lupus, Myasthenia Gravis, and Goodpasture’s syndrome. * **Dermatology Link:** It can cause **Elastosis Perforans Serpiginosa (EPS)** due to its effect on collagen cross-linking.

Question 356: Which of the following is NOT a sign of Organophosphorus poisoning?

A. Bradycardia
B. Salivation
C. Miosis
D. Bronchodilatation (Correct Answer)

Explanation: **Explanation:** Organophosphorus (OP) compounds act by irreversibly inhibiting the enzyme **Acetylcholinesterase (AChE)**. This leads to an accumulation of Acetylcholine (ACh) at both muscarinic and nicotinic receptors, resulting in a "cholinergic crisis." **Why Bronchodilatation is the correct answer:** In OP poisoning, excess ACh stimulates **M3 receptors** in the bronchial smooth muscle, leading to **bronchoconstriction** and increased bronchial secretions (bronchorrhea). Bronchodilatation is a sympathetic (adrenergic) response, not a cholinergic one. Therefore, it is NOT a sign of OP poisoning. **Analysis of Incorrect Options:** * **Bradycardia:** Excess ACh stimulates **M2 receptors** in the heart (specifically the SA node), leading to a decrease in heart rate. * **Salivation:** Stimulation of **M3 receptors** in the exocrine glands causes profuse sweating, lacrimation, and salivation (part of the SLUDGE mnemonic). * **Miosis:** ACh acts on the **M3 receptors** of the sphincter pupillae muscle, causing pupillary constriction (pin-point pupils). **NEET-PG High-Yield Pearls:** * **Mnemonics:** Remember **DUMBELS** (Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm, Emesis, Lacrimation, Salivation) or **SLUDGE**. * **Nicotinic Effects:** While muscarinic effects are common, OP poisoning also causes nicotinic effects like muscle fasciculations and weakness. * **Management:** The specific antidote is **Atropine** (reverses muscarinic effects; dose titrated until "atropinization" i.e., clearing of secretions). **Pralidoxime (2-PAM)** is used as a cholinesterase regenerator if given before "aging" of the enzyme occurs. * **Cause of Death:** Usually respiratory failure due to bronchoconstriction, excessive secretions, and paralysis of respiratory muscles.

Question 357: Which of the following monoclonal antibodies is directed against alpha 4 integrin?

A. Efalizumab
B. Natalizumab (Correct Answer)
C. Ibalizumab
D. Tocilizumab

Explanation: **Explanation:** **Natalizumab** is a humanized monoclonal antibody that targets the **$\alpha$4-subunit of integrins** ($\alpha$4$\beta$1 and $\alpha$4$\beta$4) [1], [2]. These integrins are expressed on the surface of all leukocytes except neutrophils [1]. By binding to $\alpha$4-integrin, Natalizumab prevents leukocytes from adhering to the Vascular Cell Adhesion Molecule-1 (VCAM-1) on the blood-brain barrier and intestinal lining [2]. This inhibits the migration of inflammatory cells into the CNS and gut, making it highly effective for **Multiple Sclerosis** and **Crohn’s disease** [1], [2]. **Analysis of Incorrect Options:** * **Efalizumab:** Targets **CD11a**, a subunit of Leukocyte Function-associated Antigen-1 (LFA-1). It was used for psoriasis but was withdrawn due to the risk of Progressive Multifocal Leukoencephalopathy (PML). * **Ibalizumab:** A "post-attachment inhibitor" that binds to the **CD4 receptor**, preventing HIV-1 from entering host cells. * **Tocilizumab:** An **Interleukin-6 (IL-6) receptor antagonist** used in Rheumatoid Arthritis, Giant Cell Arteritis, and Cytokine Release Syndrome (CRS). **High-Yield Clinical Pearls for NEET-PG:** * **PML Risk:** The most significant adverse effect of Natalizumab is **Progressive Multifocal Leukoencephalopathy (PML)**, caused by the reactivation of the **JC virus** [2]. Patients must be screened for anti-JCV antibodies before starting therapy. * **Integrin Targets:** * $\alpha$4$\beta$7 integrin (gut-specific): **Vedolizumab** (used in Ulcerative Colitis). * $\alpha$IIb$\beta$3 integrin (platelets): **Abciximab** (antiplatelet agent). * **Mnemonic:** "Nata-**4**-zumab" for **$\alpha$4**-integrin.

Question 358: Which of the following statements about cyclosporine is false?

A. It is given only orally. (Correct Answer)
B. It is given in renal transplant.
C. It selectively inhibits T-lymphocyte proliferation.
D. It causes renal toxicity.

Explanation: ### Explanation **1. Why Option A is the Correct Answer (False Statement):** Cyclosporine is **not** given only orally. It has a variable and incomplete absorption from the gastrointestinal tract (bioavailability ~30%). Therefore, it is available in both **oral** (capsules/solution) and **intravenous (IV)** formulations. The IV route is typically reserved for patients who cannot tolerate oral medication or those in the immediate post-transplant period. Additionally, it is used topically as ophthalmic drops for dry eyes (Sjögren’s syndrome). **2. Analysis of Incorrect Options (True Statements):** * **Option B:** Cyclosporine is a cornerstone in **solid organ transplantation**, including renal, hepatic, and cardiac transplants, to prevent graft rejection. * **Option C:** It is a **calcineurin inhibitor**. It binds to cyclophilin, forming a complex that inhibits calcineurin. This prevents the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells), leading to decreased IL-2 production and selective inhibition of T-lymphocyte proliferation. * **Option D:** **Nephrotoxicity** is the most common and serious adverse effect of cyclosporine. It causes dose-related constriction of afferent arterioles, leading to decreased GFR. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Calcineurin Inhibitor → ↓IL-2 → ↓T-cell activation. * **Adverse Effect Mnemonic (6 H's):** **H**ypertension, **H**yperplasia of gums (gingival hyperplasia), **H**irsutism, **H**yperlipidemia, **H**yperkalemia, and **H**epatotoxicity (along with Nephrotoxicity). * **Monitoring:** It requires **Therapeutic Drug Monitoring (TDM)** due to its narrow therapeutic index and cytochrome P450 (CYP3A4) mediated metabolism. * **Comparison:** Unlike Tacrolimus (another calcineurin inhibitor), Cyclosporine is more likely to cause hirsutism and gum hyperplasia, whereas Tacrolimus is more associated with hyperglycemia/diabetes.

Question 359: Which of the following drugs is deposited in the retina?

A. Isoniazid
B. Chloroquine (Correct Answer)
C. Rifampicin
D. Pyrazinamide

Explanation: **Explanation:** **Chloroquine (Option B)** is the correct answer because it has a high affinity for melanin-containing tissues. The drug binds to melanin in the **retinal pigment epithelium (RPE)**, leading to its accumulation and subsequent damage to the photoreceptors. This toxicity manifests clinically as **"Bull’s Eye Maculopathy"** (a central area of depigmentation surrounded by a ring of hyperpigmentation). Because chloroquine has a very large volume of distribution and a long half-life, it remains deposited in the retina long after the drug is discontinued, necessitating regular ophthalmological screening (Amsler grid test, Fundus examination). **Why the other options are incorrect:** * **Isoniazid (Option A):** Primarily associated with **Optic Neuritis** (inflammation of the optic nerve) rather than retinal deposition. It also causes peripheral neuropathy due to Vitamin B6 (pyridoxine) deficiency. * **Rifampicin (Option C):** Known for causing harmless **orange-red discoloration** of body secretions (tears, sweat, urine) but does not deposit in or damage the retinal tissue. * **Pyrazinamide (Option D):** Its most significant side effects are hepatotoxicity and hyperuricemia (leading to gout); it has no significant ocular toxicity. **High-Yield Clinical Pearls for NEET-PG:** 1. **Bull’s Eye Maculopathy:** Classic buzzword for Chloroquine/Hydroxychloroquine toxicity. 2. **Vigabatrin:** Another high-yield drug causing "permanent concentric visual field loss." 3. **Ethambutol:** Most common anti-tubercular drug causing **Retrobulbar Neuritis** (red-green color blindness). 4. **Thioridazine:** An antipsychotic also known for causing pigmentary retinopathy.

Question 360: A patient presents with bleeding due to warfarin overdose. As a treating physician, what is the immediate treatment for warfarin-induced bleeding?

A. Cryoprecipitate
B. Platelet concentrate
C. Fresh frozen plasma (Correct Answer)
D. Vitamin K injection

Explanation: **Explanation:** The management of warfarin toxicity depends on the severity of bleeding and the INR levels. Warfarin acts by inhibiting **Vitamin K Epoxide Reductase (VKOR)**, leading to a deficiency of active clotting factors **II, VII, IX, and X**. **Why Fresh Frozen Plasma (FFP) is correct:** In the event of **active bleeding** due to warfarin, the priority is the immediate replacement of functional clotting factors. FFP contains all coagulation factors and provides a rapid reversal of the anticoagulant effect. While **Prothrombin Complex Concentrate (PCC)** is technically the first-line treatment for life-threatening bleeds (as it works faster and avoids fluid overload), **FFP** is the standard correct choice among the provided options for immediate reversal in a clinical setting. **Analysis of Incorrect Options:** * **Vitamin K Injection (Option D):** While Vitamin K is the specific antidote for warfarin, it acts by promoting the hepatic synthesis of *new* clotting factors. This process takes **6–24 hours** to show effect, making it unsuitable for "immediate" control of active bleeding. * **Cryoprecipitate (Option A):** This is rich in Fibrinogen, Factor VIII, Factor XIII, and vWF. It is primarily used for hemophilia A, von Willebrand disease, or hypofibrinogenemia, not for warfarin reversal. * **Platelet Concentrate (Option B):** Warfarin affects soluble clotting factors, not platelet count or function. Platelet transfusion is indicated in thrombocytopenia or antiplatelet drug toxicity. **High-Yield NEET-PG Pearls:** * **Antidote for Warfarin:** Vitamin K (Phytonadione). * **Immediate Reversal:** PCC (Best) > FFP (Next best). * **Monitoring:** Warfarin is monitored by **PT/INR** (Extrinsic pathway). * **Teratogenicity:** Warfarin causes **Fetal Warfarin Syndrome** (stippled epiphyses, nasal hypoplasia); it is contraindicated in pregnancy (except for mechanical heart valves in specific trimesters).

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free